
Photoactivated psoralens were studied in sixty cases of tuberculoid leprosy for the repigmentation of hypopigmented macules. It was observed that in 42 (70%) cases there was significant repigmentation within 6 months of therapy; in 5 (8.33%) cases there was mild to moderate repigmentation and in 13 (22.64%) cases, there was no change. No significant untoward effects of drug were encountered, except in four patients (6.66%), who developed, marked erythema and eczematous reaction.
Male, Sex Factors, Humans, Female, Leprosy, Tuberculoid, PUVA Therapy, Pigmentation Disorders
Male, Sex Factors, Humans, Female, Leprosy, Tuberculoid, PUVA Therapy, Pigmentation Disorders
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
